Key Insights

Highlights

Success Rate

85% trial completion

Research Maturity

51 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.8%

9 terminated out of 115 trials

Success Rate

85.0%

-1.6% vs benchmark

Late-Stage Pipeline

6%

7 trials in Phase 3/4

Results Transparency

18%

9 of 51 completed with results

Key Signals

9 with results85% success

Data Visualizations

Phase Distribution

85Total
Not Applicable (39)
Early P 1 (1)
P 1 (24)
P 2 (14)
P 3 (7)

Trial Status

Completed51
Recruiting25
Unknown11
Active Not Recruiting9
Terminated9
Not Yet Recruiting8

Trial Success Rate

85.0%

Benchmark: 86.6%

Based on 51 completed trials

Clinical Trials (115)

Showing 20 of 20 trials
NCT07292818Phase 1RecruitingPrimary

Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies

NCT05521997Phase 2Not Yet Recruiting

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

NCT05864144Phase 1Completed

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT06904365Recruiting

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

NCT07624123Not ApplicableNot Yet RecruitingPrimary

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV

NCT02997553Phase 3Completed

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

NCT07545746Phase 2Not Yet Recruiting

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

NCT07294066Not ApplicableNot Yet RecruitingPrimary

Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina

NCT05063916Phase 2Active Not Recruiting

Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix

NCT01325961Not ApplicableCompleted

Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers

NCT06002126Not ApplicableActive Not RecruitingPrimary

Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries

NCT04072913Not ApplicableCompleted

Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix

NCT05743517Not ApplicableRecruiting

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

NCT07428330Not ApplicableRecruitingPrimary

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT03144466Phase 1TerminatedPrimary

A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer

NCT07595224Not ApplicableRecruiting

Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer

NCT06043947Active Not Recruiting

Survival Monitoring in Russian Cancer Registries

NCT06266338Phase 2RecruitingPrimary

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

NCT01549730Not ApplicableActive Not RecruitingPrimary

Cervix Hypoxia FAZA

NCT07146919Phase 1Withdrawn

AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer

Scroll to load more

Research Network

Activity Timeline